Great news!

We are happy to announce that Bidi Vapor has been granted a stay order by the FDA.

Which means all 11 flavors of the BIDI®️ Stick are now legal to market and distribute as the FDA is currently reviewing the previously released MDO.


February 3, 2022

Bidi Vapor Wins Judicial Stay of FDA’s Marketing Denial Order

U.S. Circuit Court allows Bidi Vapor and Kaival Brands to market and sell after being granted a judicial stay of the marketing denial order (MDO) previously issued by the FDA last September 2021.
February 17, 2022

Kaival Brands Reports Fiscal 2021 Year End Results

GRANT, Fla., Feb. 16, 2022 /PRNewswire/ — Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) (“Kaival Brands,” the “Company,” or “we”), is the exclusive global distributor of products manufactured by Bidi Vapor LLC (“Bidi Vapor”) ...
March 15, 2022

Synthetic Nicotine Placed Under FDA Authority

MELBOURNE, Fla. (March 11, 2022) – In a $1.5 trillion federal funding bill passed on March 10, 2022, Congress included a measure to grant the U.S. Food and Drug Administration (FDA) authority over synthetic nicotine, according to the Winston-Salem Journal.
March 27, 2022

Selling Synthetic Nicotine?

With the U.S. Food and Drug Administration (FDA) receiving authority over nicotine-delivery products containing synthetic nicotine, the question for retailers is where to go next. E-cigarette maker Bidi Vapor, LLC, suggests partnering with brands that comply with federal, state, and local regulations.
Bidi vapor - forma

ADVISORY: We will temporarily stop all sales and shipping of Bidi Vapor products from March 27-31, 2021, due to systems upgrades and tax integration. We will resume regular business operations on April 1, 2021.

error: Alert: Content is protected!
Skip to content